The status of pulmonary arterial hypertension in 2008.
Harrison W
HW
Farber
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D011464:Epoprostenol / Q000627:therapeutic use*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D010666:Phenylpropionates / Q000627:therapeutic use*; D011724:Pyridazines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D010666:Phenylpropionates; D011724:Pyridazines; D014665:Vasodilator Agents; D011464:Epoprostenol; C467894:ambrisentan